SYK and liver disorder: Therefore, the non-hepatic SYK, such as the SYK in spleen monocytes, could be an important therapeutic target for liver diseases, and the therapeutic action of splenectomy against liver diseases may be also relevant with the inhibition of non-hepatic SYK.